Latest News in the pharma Industry
Biopharma News
Sphere Fluidics expands to increase supply of surfactant for droplet microfluidics
18 Feb 2020
Investment in resources to meet demand for large-scale supply of patented biocompatible surfactant.
Read more
Sartorius sharpens its brand focus
17 Feb 2020
The company aims to simplify its customers’ work and thus help them to achieve medical progress and make innovative medicines available faster.
Read more.jpg)
BD completes clinical trial for its wearable injector
11 Feb 2020
The pre-filled, pre-assembled injector is designed to prioritize safety, convenience and usability while delivering high-value drug treatments in the comfort of an in-home environment.
Read more.jpg)
Catalent to manufacture first-in-class mAb targeting solid tumours
11 Feb 2020
ZM008 could have potential benefits for the treatment of prostate cancer.
Read more.jpg)
Inovio and Beijing Advaccine to advance vaccine against Coronavirus
30 Jan 2020
Agreement will facilitate clinical trial translations in China.
Read more.jpg)
First human trial of monoclonal antibody to prevent malaria opens
28 Jan 2020
If proven safe and effective, mAb CIS43LS might be used prophylactically by tourists, medical workers or military personnel who travel to areas where malaria is common.
Read more.jpg)
Merck invests in biotech development facility in Switzerland
27 Jan 2020
€250 million to be invested during the 2019-2022 period in new facility bridging research and manufacturing.
Read more.jpg)
Grey Wolf Therapeutics secures funding for cancer therapies development
21 Jan 2020
The company targets ERAP antigen presentation pathways with the aim of ‘illuminating’ non-responsive tumours for attack and destruction by the immune system.
Read more
Wuxi to acquire Bayer final drug product manufacturing site
17 Jan 2020
First drug product facility in Europe to complement WuXi Biologics’ existing commercial manufacturing capacities.
Read more
BioMarin gets go-ahead to start gene therapy clinical trials
15 Jan 2020
BMN 307 represents a potential third PKU treatment option from BioMarin and its second gene therapy clinical program.
Read more
Partnership formed to develop and commercialise ready-to-use medicine
13 Jan 2020
The product being developed will use proprietary drug formulation technology platform Arestat to deliver new reformulations of existing, complex products.
Read more
UCB to build new biotech manufacturing plant in Belgium
31 Dec 2019
Capacity to serve global late-stage development and commercial manufacturing of monoclonal antibody drug substance to support new product launches.
Read more